Meeting Presentations
Following are links to the presentations from the DGS Meeting held here at Vanderbilt on July 21-23, 2005.
“Pharmacology’s Future: Avoiding the Suffocation of the Bell Jar” Lee Limbird, Ph.D. Vice President for Research and Chair, Department of Biomedical Sciences,Meharry Medical College, Nashville, Tennessee |
|||
Dennis Hall, Assoc Provost Research and Graduate Education and Professor of Physics,Vanderbilt University, Nashville, Tennessee |
|||
“Pharmacologists as Dinomammals: The Changing Face of Pharmacology” Robert Gould, Ph.D., Senior Vice President, Merck Pharmaceuticals, Boston, Massachusetts |
|||
“What the Pharmaceutical Industry requires for success” Marlene Cohen, Ph.D., Distinguished Lilly Fellow (retired), Eli Lilly and Company, Adjunct Professor of Pharmacology, Indiana University School of Medicine, and Vice President, Creative Pharmacology Solutions LLC, Carmel, Indiana |
|||
“The World of West Coast Biotechs: Needs and Opportunities” Franz F. Hefti, Ph.D., Executive Vice President, Drug Development, Rinat Neuroscience, Palo Alto, California |
|||
“An Academic Perspective to ‘Marketing’ Pharmacology” Barbara Beckman, Ph.D., Professor of Pharmacology and Assistant Dean of Admissions, Tulane Medical School, New Orleans, Louisiana |
|||
“Interdisciplinary Umbrella Programs…perceptions on the Vanderbilt IGP after 14 years” Roger Chalkley, D. Phil., Senior Associate Dean, Biomedical Research Education & Training, Vanderbilt University, Nashville, Tennessee |
|||
“Representing the Underrepresented” Lou DeFelice, Ph.D., Professor of Pharmacology and Neuroscience, Director of the Vanderbilt Bridges Program, Vanderbilt University, Nashville, Tennessee |
|||
“Task Force on Learning Objectives for Graduate Students in Pharmacology” J. R. Haywood, Ph.D., Professor and Chairperson, Pharmacology and Toxicology, MichiganState University, East Lansing, Michigan |
|||
Curriculum Presentations Richard Robinson, PhD, Columbia University Lonny Levin, PhD, Cornell University David Riddick, PhD, University of Toronto Lee Graves, PhD, University of North Carolina at Chapel Hill Robert Speth, PhD, University of Mississippi Brian Knoll, PhD, University of Houston Edward Morgan, PhD, Emory University |
|||
Breakout Sessions: |
|||
|
VICC Room A Topic |
VICC Room B Topic |
VICC Room C Topic |
Session 1:
3:15 pm – 4:00 pm |
Undergraduate Programs (Discussion Leader: B. Beckman)
Hamm |
Umbrella Programs (Discussion Leaders: R. Chalkley and J. Barnett)
Elton |
Master’s Degrees (Discussion Leaders: JR Haywood, J. Lucot) |
Session 2:
4:00 pm – 4:45 pm |
Curriculum Issues (Discussion Leader: R. Robinson)
|
Minority Issues (Discussion Leader: L. DeFelice)
|
NIH (Discussion Leaders: P. Preusch & A. Zajicek)
|
Session 3:
4:45 pm – 5:30 pm |
Curriculum Issues (Discussion Leader: Y. Tu)
|
Umbrella Programs (Discussion Leader: R. Chalkley) |
NIH (Discussion Leaders: P. Preusch & A. Zajicek)
|
Joey Barnett, Ph.D., Vice-Chair in Pharmacology, Director of Graduate Studies in Pharmacology, Associate Professor of Pharmacology, Medicine and Microbiology & Immunology, Vanderbilt University, Nashville, Tennessee |
|||
“Pharmacological Sciences Training Grants – Progress Report” Peter Preusch, Ph.D., NIGMS Training Grant Program Director, National Institutes of Health,Bethesda, Maryland |
|||
“Pediatric Clinical Pharmacology: What’s new at the NIH” Anne Zajicek, M.D./Pharm.D., Pediatric Medical Officer, National Institutes of Health, Bethesda,Maryland |
During this historic meeting, we asked participants to complete a questionnaire/survey of their Pharmacology program. Dr. Barnett presented some of the preliminary data during the Business Meeting (see link, above). For the blind final data analysis, click here. For comments on the challenges and opportunities faced by various institutions, click here. If you prefer the unblinded data, please contact Dr. Barnett at joey.barnett@vanderbilt.edu and he will be happy to accommodate your request.
To access a PowerPoint summary of the data, click here.